NO20004614L - Mutante rekombinante allergener - Google Patents

Mutante rekombinante allergener

Info

Publication number
NO20004614L
NO20004614L NO20004614A NO20004614A NO20004614L NO 20004614 L NO20004614 L NO 20004614L NO 20004614 A NO20004614 A NO 20004614A NO 20004614 A NO20004614 A NO 20004614A NO 20004614 L NO20004614 L NO 20004614L
Authority
NO
Norway
Prior art keywords
allergens
recombinant allergens
mutant recombinant
disclosed
recombinant
Prior art date
Application number
NO20004614A
Other languages
English (en)
Other versions
NO328354B1 (no
NO20004614D0 (no
Inventor
Hans Henrik Ipsen
Michael Dho Spangfort
Joergen Nedergaard Larsen
Original Assignee
Alk Abello As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8092687&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20004614(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alk Abello As filed Critical Alk Abello As
Publication of NO20004614D0 publication Critical patent/NO20004614D0/no
Publication of NO20004614L publication Critical patent/NO20004614L/no
Publication of NO328354B1 publication Critical patent/NO328354B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
NO20004614A 1998-03-16 2000-09-15 Mutante rekombinante allergener, fremgangsmate for fremstilling, farmasoytisk sammensetning og anvendelse. NO328354B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK36498 1998-03-16
PCT/DK1999/000136 WO1999047680A1 (en) 1998-03-16 1999-03-16 Mutant recombinant allergens

Publications (3)

Publication Number Publication Date
NO20004614D0 NO20004614D0 (no) 2000-09-15
NO20004614L true NO20004614L (no) 2000-10-26
NO328354B1 NO328354B1 (no) 2010-02-01

Family

ID=8092687

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004614A NO328354B1 (no) 1998-03-16 2000-09-15 Mutante rekombinante allergener, fremgangsmate for fremstilling, farmasoytisk sammensetning og anvendelse.

Country Status (20)

Country Link
US (1) US20040091500A1 (no)
EP (1) EP1062341B1 (no)
JP (1) JP2002506648A (no)
KR (1) KR20010041918A (no)
CN (1) CN1332029C (no)
AT (1) ATE408690T1 (no)
AU (1) AU749749B2 (no)
CA (1) CA2323687C (no)
DE (1) DE69939584D1 (no)
DK (1) DK1062341T3 (no)
ES (1) ES2313776T3 (no)
HK (1) HK1033591A1 (no)
HU (1) HUP0101464A3 (no)
IL (2) IL138339A0 (no)
NO (1) NO328354B1 (no)
NZ (1) NZ506665A (no)
PL (1) PL194804B1 (no)
PT (1) PT1062341E (no)
WO (1) WO1999047680A1 (no)
ZA (1) ZA200004819B (no)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020192792A1 (en) * 2000-04-28 2002-12-19 Palle Schneider Laccase mutants
IT1318692B1 (it) * 2000-09-12 2003-08-27 Consiglio Nazionale Ricerche Varianti di proteine allergeniche di phleum pratense.
IT1318690B1 (it) * 2000-09-12 2003-08-27 Consiglio Nazionale Ricerche Varianti dell'allergene maggiore par j 2 di parietaria judaica.
EP1340085B1 (en) * 2000-10-17 2008-07-30 Besst-Test Aps Assay for directly detecting a biological cell in a body fluid sample
MXPA03004174A (es) * 2000-11-16 2004-12-02 Alk Abello As Alergenos mutantes novedosos.
EP1219300B1 (en) * 2000-12-28 2006-12-06 BIOMAY Produktions- und Handels- Aktiengesellschaft Treatment of allergies
CA2441476A1 (en) * 2001-03-02 2002-09-12 The Rockefeller University Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen
CA2462651A1 (en) * 2001-10-05 2003-04-17 Novozymes A/S Kit for predicting binding of a specific antibody to a potential immunogen and method of screening
CN1668737A (zh) * 2002-05-16 2005-09-14 阿尔克-阿贝洛有限公司 重组Bet.V.1过敏原突变体及其方法和制备
CA2503886A1 (en) * 2002-11-01 2004-05-13 Alk-Abello A/S Recombinant protein variants
WO2004047793A1 (en) 2002-11-26 2004-06-10 Alk-Abelló A/S Pharmaceutical allergen product
WO2004075875A1 (en) 2003-02-28 2004-09-10 Alk-Abello A/S Dosage form having a saccharide matrix
US8012505B2 (en) 2003-02-28 2011-09-06 Alk-Abello A/S Dosage form having a saccharide matrix
BRPI0417264A (pt) 2003-12-19 2007-03-06 Alk Abello As processos para a preparação de uma batelada de um ingrediente farmacêutico ativo, um recipiente compreendendo criogránulos de um produto alérgeno, e um criogránulo de um produto alérgeno
CA2624503A1 (en) 2005-10-04 2007-04-12 Alk-Abello A/S Solid vaccine formulation
ITMI20052517A1 (it) 2005-12-29 2007-06-30 Lofarma Spa Varianbtio ipoallergeniche dell'allergene maggiore bet v 1 di polline di betula verrucosa
JP2009534029A (ja) * 2006-04-20 2009-09-24 ナショナル ユニバーシティ オブ シンガポール 組換え乳酸桿菌およびその使用
ES2527412T3 (es) * 2007-02-15 2015-01-23 Mannkind Corporation Método para aumentar la respuesta de los linfocitos T
EP1974746B1 (en) 2007-03-28 2012-01-11 Alk-Abelló A/S Use of an adjuvanted allergy vaccine formulation for parenteral administration
EP2028188A1 (en) 2007-08-21 2009-02-25 Biomay AG Hypoallergenic molecules
DE202008006598U1 (de) 2008-04-11 2008-10-02 Alk-Abelló A/S Allergie-Impfstoff-Formulierung zur mucosalen Verabreichung
WO2010146171A1 (en) 2009-06-19 2010-12-23 Alk-Abelló A/S Novel manner of administering allergen in allergen specific immunotherapy
CN102584966A (zh) * 2011-11-14 2012-07-18 广州医学院第二附属医院 一种重组花生过敏原与突变体及其制备方法和应用
CN102690340A (zh) * 2012-03-30 2012-09-26 广州医学院第二附属医院 一种重组巴西坚果过敏原与突变体及其制备方法和应用
CN102617719A (zh) * 2012-03-30 2012-08-01 广州医学院第二附属医院 一种重组大米过敏原与突变体及其制备方法和应用
CN102617715A (zh) * 2012-03-30 2012-08-01 广州医学院第二附属医院 一种重组真菌主要过敏原与突变体及其制备方法和应用
CN102603879A (zh) * 2012-03-30 2012-07-25 广州医学院第二附属医院 一种重组大豆过敏原与突变体及其制备方法和应用
CN102675439A (zh) * 2012-03-31 2012-09-19 广州医学院第二附属医院 一种重组黑麦草花粉过敏原与突变体的制备方法和应用
EP2952200A1 (en) 2014-06-04 2015-12-09 Alk-Abelló A/S Allergen for prophylactic treatment of allergy
CN111187606B (zh) * 2020-02-25 2022-06-14 江苏海洋大学 一种用于海水基可循环清洁压裂液的表面活性剂及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804201A (en) * 1996-03-11 1998-09-08 The Rockefeller University Immunomodulatory peptides of vespid antigen 5
CA2319437C (en) * 1998-01-31 2009-06-16 University Of Arkansas Methods and reagents for decreasing allergic reactions
IT1318692B1 (it) * 2000-09-12 2003-08-27 Consiglio Nazionale Ricerche Varianti di proteine allergeniche di phleum pratense.

Also Published As

Publication number Publication date
IL138339A (en) 2009-06-15
HUP0101464A2 (hu) 2001-08-28
PL343029A1 (en) 2001-07-30
NO328354B1 (no) 2010-02-01
DE69939584D1 (de) 2008-10-30
AU2714799A (en) 1999-10-11
HUP0101464A3 (en) 2004-10-28
CN1332029C (zh) 2007-08-15
WO1999047680A1 (en) 1999-09-23
ES2313776T3 (es) 2009-03-01
CA2323687A1 (en) 1999-09-23
KR20010041918A (ko) 2001-05-25
IL138339A0 (en) 2001-10-31
US20040091500A1 (en) 2004-05-13
CA2323687C (en) 2008-11-25
AU749749B2 (en) 2002-07-04
PL194804B1 (pl) 2007-07-31
EP1062341B1 (en) 2008-09-17
HK1033591A1 (en) 2001-09-07
JP2002506648A (ja) 2002-03-05
CN1293710A (zh) 2001-05-02
DK1062341T3 (da) 2008-11-03
NO20004614D0 (no) 2000-09-15
NZ506665A (en) 2003-08-29
EP1062341A1 (en) 2000-12-27
ATE408690T1 (de) 2008-10-15
ZA200004819B (en) 2001-05-30
PT1062341E (pt) 2008-12-24

Similar Documents

Publication Publication Date Title
DK1062341T3 (da) Muterede rekombinante allergener
ATE414773T1 (de) Mutante allergene
WO2004043361A3 (en) Compositions and methods for the treatment of natural killer cell related diseases
WO2004024097A8 (en) Compositions and methods for the treatment of immune related diseases
WO2004047728A3 (en) Compositions and methods for the treatment of immune related diseases
WO2004039956A3 (en) Compositions and methods for the treatment of immune related diseases
MXPA04002593A (es) Composiciones y metodos para el diagnostico y tratamiento de tumor.
MXPA03011985A (es) Composiciones y metodos para el diagnostico y tratamiento de tumores.
HUP0302965A2 (hu) Vakcina
AU3227700A (en) Skin sanitizing compositions
BG102818A (en) D-manitol and method for its preparation
IL145795A0 (en) Mutant human cd80 and compositions for and methods of making and using the same
ATE284708T1 (de) T-zellimpfung zur behandlung von multiple sclerosis
WO2004024072A3 (en) Novel compositions and methods for the treatment of immune related diseases
WO2001040465A3 (en) Compositions and methods for the treatment of immune related diseases
TR199700416A2 (xx) Fluorinlenmi� vitamin D3 analoglar�.
DE60134408D1 (de) Für akzessorische hiv proteine kodierende dna impfstoffe
NZ514027A (en) Cloning and expression of haemophilus somnus transferrin-binding proteins
AU7079300A (en) Compositions and methods for the treatment of immune related diseases
EP1689430A4 (en) TYROSINE MUTANT AND METHOD OF USE THEREOF
IT1294932B1 (it) Uso di 2-amminotetraline-6,7 sostituite per la preparazione di composizioni farmaceutiche atte al trattamento di patologie

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees